MALAT1 and cancer: Indeed, in unpublished work from our lab, CRISPR activation-guided epigenetic overexpression of endogenous Malat1 in an autochthonous mouse model of lung adenocarcinoma confirmed that increased Malat1 expression is a driver of cancer progression.